Bionor (Norway)

Bionor (Norway)

Bionor Holding AS is a Norwegian biotechnology company, developing vaccines targeted at rapidly mutating virus infections such as HIV, Hepatitis C and Influenza. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Bionor (Norway), Norway, covering academic research published from 2002 to 2024. Read More.


Open Access Percentage

65%


Total
Publications

66


Total Open
Publications

43


Total
Citations

1.3K


Open Access
Percentage

65%


Total
Publications

66


Total Open
Publications

43


Total
Citations

1.3K

Wikipedia

Website

download

Breakdown

36% 23% 6% 35%

Publisher Open

36%

Both

23%

Other Platform Open

6%

Closed

35%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

012345678910Total Publications
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

31%OA Journal

OA Journal 31%

12

Hybrid 49%

19

No Guarantees 20%

8

Other Platform Open

Institution 47%

9

Domain 37%

7

Public 37%

7

Other Internet 16%

3

Preprint 11%

2

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
7
Semantic Scholar
Public
6
Europe PMC
Domain
4
Université de Lausanne - SERVAL
Institution
3
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia
Institution
3
University of Oslo - Duo Research Archive
Institution
2
Unknown Repository
Other Internet
1
University of Melbourne - Minerva Access
Institution
1
University of Groningen / Centre for Information Technology - University of Groningen research database
Institution
1
University of California - eScholarship University of California
Institution
1
1 / 2

Data updated 13 February 2025

Share

Share

Share